Up 21% since its later-stage round, Jan 2025 ($420.0M post-money).
- ·6 fund marks: filer, period, implied $/share
Membership and data by Private Market View
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Umoja Biopharma funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2021 | Later Stage VC | $210.0M | ▮ | ▮ |
Membership and data by Private Market View
Umoja Biopharma valuation
Umoja Biopharma is valued at approximately $509 million as of Oct 2026. The figure is set by institutional fund marks. The reference point is its later-stage round in Jan 2025, at a $420 million post-money valuation; the current figure is up 21% since.
Recent activity
In the last 90 days, Umoja Biopharma's record added 1 institutional fund mark (latest period Jul 2026).
How much has Umoja Biopharma raised?
Umoja Biopharma has raised $371 million in total; 1 of its rounds is on record. The largest on record was a $210 million later-stage round in Jun 2021.
Umoja Biopharma has filed 1 Form D with the SEC, most recently in Jun 2021 ($210 million sold to 29 investors).
Institutional holders and vehicles
1 SEC-registered fund reported 6 fair-value marks on Umoja Biopharma between Apr 2025 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
How Umoja Biopharma's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Umoja Biopharma, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by institutional fund marks. Question about this number? Full methodology →
Frequently asked about Umoja Biopharma
- What is Umoja Biopharma worth?
- Umoja Biopharma is valued at $508.8M as of Oct 2026. Up 21% since its later-stage round, Jan 2025 ($420.0M post-money).
- How much has Umoja Biopharma raised?
- Umoja Biopharma has raised $371.0M in total funding across 1 recorded rounds.
- When did Umoja Biopharma last raise?
- Umoja Biopharma last raised in Jun 2021 (Later Stage VC), raising $210.0M.